(Q35586312)

9 August 2017

0 references

1 reference

title

Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review (English)

1 reference

chronic cancer related pain

9 August 2017

main subject

0 references

0 references

1 reference

Anesthesiology and pain medicine

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

2 April 2024

7

Joseph Lau

1 reference

9 August 2017

Ewan McNicol

1

1 reference

9 August 2017

Nathalie Horowicz-Mehler

2

1 reference

9 August 2017

Kyle Bennett

4

1 reference

9 August 2017

Maria Gialeli-Goudas

5

1 reference

9 August 2017

Daniel Carr

8

1 reference

9 August 2017

Americal Pain Society

9

1 reference

9 August 2017

Ruth A. Fisk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622694

2 April 2024

Priscilla W. Chew

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622694

2 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14622694

2 April 2024

publication date

1 June 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S152659000300556X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

https://api.elsevier.com/content/article/PII:S152659000300556X?httpAccept=text/plain

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

2 April 2024

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

231-256

1 reference

Advances in pain management for older adult patients

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Fentanyl neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Efficacy of senna versus lactulose in terminal cancer patients treated with opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Reduction of nausea and vomiting from epidural opioids by adding droperidol to the infusate in home-bound patients

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Itching after epidural and spinal opiates

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

"Invisible" synthetic opiates and acute psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Myoclonic spasms following intrathecal diamorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Opioid analgesics: comparative features and prescribing guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Strategies to manage the adverse effects of oral morphine: an evidence-based report.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Treatment of opioid-induced constipation with oral naloxone: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Reversible delirium in terminally ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Reversible delirium during opiod switching from transdermal fentanyl to methadone

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

ABC of palliative care. Constipation and diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Morphine, constipation and performance status in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Transdermal scopolamine use in the control of narcotic-induced nausea

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Naloxone reversal of buprenorphine-induced respiratory depression

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Myoclonic spasms following intrathecal morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Continuous midazolam infusion for the management of morphine-induced myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Intrathecal morphine: naloxone reverses respiratory depression but not analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Hear my song: auditory hallucinations with tramadol hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Inhibition of apomorphine-induced vomiting by benzquinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Antagonism of morphine-induced respiratory depression with nalmefene

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Acute toxic delirium: an uncommon reaction to transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Management of opioid-induced pruritus: a role for 5-HT3 antagonists?

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

[Treament of morphine-induced constipation with oral naloxone]

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Intralingual naloxone injection for narcotic-induced respiratory depression

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Oral naloxone reverses opioid-associated constipation

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Opioid rotation for cancer pain: rationale and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Ondansetron in nausea and vomiting induced by spinal morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

The effect of low-dose ketamine on fentanyl-induced respiratory depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Opioid-induced delay in gastric emptying: a peripheral mechanism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Constipation in the cancer patient: causes and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

When all oral opioids cause nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Epidural and intravenous opioid-induced neuroexcitation

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Itch--mediators and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Adverse effects of systemic opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Donepezil in the treatment of opioid-induced sedation: report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Acute toxic delirium in a patient using transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Prevention of opioid side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Pruritus with sublingual buprenorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Oral methylnaltrexone for opioid-induced constipation

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900556-X

7 January 2021

Ethnicity influences morphine pharmacokinetics and pharmacodynamics

16

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

Dantrolene treatment of opioid-induced myoclonus

2 April 2024

63

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

Management of common opioid side effects during long-term therapy of cancer pain

2 April 2024

74

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00556-X

2 April 2024

Identifiers

1 reference

9 August 2017

1 reference